AGA Institute
An engaging mix of author interviews and expert commentary on the latest articles from Clinical Gastroenterology and Hepatology, hosted by the journals' online editor, John F. Kuemmerle, MD, AGAF.
Duration: 14:31 m - Filetype: mp3 - Bitrate: 96 KBPS - Frequency: 44100 HZ
Rome Criteria of Irritable Bowel Syndrome: Pro and Con Perspectives
Do symptom-based, Rome criteria for IBS lead to better diagnosis and treatment outcomes? Two articles in the February CGH examine this issue from pro and con perspectives. Dr. Kuemmerle hosts a discussion between both authors: Prof. Robin Spiller of University Hospital, Nottingham; and Dr. Michael Camilleri of Mayo Clinic College of Medicine.
Download
Duration: 11:21 m - Filetype: mp3 - Bitrate: 96 KBPS - Frequency: 44100 HZ
Diseases and Drugs That Increase Risk of Acute Large Bowel Ischemia
A study in the January 2010 <i>CGH</i> investigates diseases and drugs that present possible risk factors for acute large bowel ischemia (ALBI). Dr. Kuemmerle speaks with senior author Dr. George Longstreth of the University of California San Diego School of Medicine.
Download
Duration: 13:57 m - Filetype: mp3 - Bitrate: 96 KBPS - Frequency: 44100 HZ
Surgery for Gastroesophageal Reflux Disease: Esophageal Impedance to Progress?
Dr. Kuemmerle speaks with Dr. Stuart J. Spechler, author of an editorial looking at surgical treatment for gastroesophageal reflux disease (GERD) in the December issue of CGH. They also discuss a related 12-year study in the same issue that compared the effects of therapy for GERD with omeprazole with those of antireflux surgery. Dr. Spechler is chief of the Division of Gastroenterology at the Dallas Veterans Affairs Medical Center, and Professor of Medicine at UT Southwestern Medical Center in Dallas, TX.
Download



